Novavax

Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for Ebola,... Wikipedia

  • Type:  Public company
  • Traded as:  NASDAQ: nvax NVAX, Russell 1000 component, FWB
  • ISIN:  [ US6700024010]
  • Industry:  Biotechnology
  • Founded:  1987
  • Area served:  Worldwide
  • Key people:  Stanley Erck (CEO), Gregory Glenn (R&D)
  • Products:  Vaccines
  • Revenue:  US$ 475.2 million (2020)
  • Number of employees:  791(February 24, 2021)
  • Data source:  DuckDuckGo